Currently, the US vaccine supply is 20% egg-free; cell-based (from cultured cells) and the recombinant influenza vaccine have been increasing in market share quickly. By the end of 2025, will at least 51% of the American flu vaccine supply be egg-free?

If available, I will use data from the CDC to resolve this market; because of this, market resolution may be delayed until data is published.

Close date updated to 2025-12-31 6:59 pm